Cancer is a disease with complex pathological process. Current chemotherapy faces
problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem …

Precise nanomedicine has been extensively explored for efficient cancer imaging and
targeted cancer therapy, as evidenced by a few breakthroughs in their preclinical and …

The design and use of materials in the nanoscale size range for addressing medical and
health-related issues continues to receive increasing interest. Research in nanomedicine …

Angiogenesis plays a critical role within the human body, from the early stages of life (ie,
embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …

One of the attractive properties of the hollow carbon clusters, known as fullerenes, is the
possibility to use them as robust containers for other species. Although an IUPAC …

Nanomedicine involves the use of nanoparticles for therapeutic and diagnostic purposes.
During the past two decades, a growing number of nanomedicines have received regulatory …

Recently, a commercial albumin-bound paclitaxel (PTX) nanocarrier (Abraxane) was
approved as the first new drug for pancreatic ductal adenocarcinoma in almost a decade …

The interactions of nanoparticles with the soft surfaces of biological systems like cells play
key roles in executing their biomedical functions and in toxicity. The discovery or design of …

Cancer remains one of the major health problems all over the world and conventional
therapeutic approaches have failed to attain an effective cure. Tumor microenvironments …

With growing interest in cancer therapeutics, anti-angiogenic therapy has received
considerable attention and is widely administered in several types of human cancers …